Patients with clinically isolated syndromes (CIS) are prone to develop multiple sclerosis (MS). The randomized, placebo-controlled CHAMPS trial found early treatment with interferon -1a to be ...

In RRMS, the early course of the disease is characterised by intermittent relapses, and partial or complete recovery of function between exacerbations. The occurrence of relapses is a key measure of ...

Medically reviewed by Lindsay Cook, PharmD Key Takeaways MS medications can help slow the disease and manage symptoms.

Gilenya and Tascenso ODT are approved to treat relapsing forms of multiple sclerosis (MS) in adults. Gilenya and Tascenso ODT ...

Rebif (interferon beta-1a) is a prescription drug that treats certain types of multiple sclerosis. Rebif’s cost may depend on factors such as your dosage, whether ...

Rebif is a brand-name liquid solution that’s typically self-injected. It’s prescribed for certain forms of multiple sclerosis (MS) and contains the active ingredient interferon beta-1a. It is not ...